文献速递神经核医学肿瘤 PET/CT

使用动态全身[11C]CFT PET/CT探索帕金森病中黑质纹状体与消化系统的相互作用

Exploring the nigrostriatal and digestive interplays in Parkinson's disease using dynamic total-body [11C]CFT PET/CT.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2024-02-23

本研究回顾性纳入11名参与者(6名健康对照和5名帕金森病患者),采用全身PET/CT扫描仪进行75分钟动态[11C]CFT扫描,通过简化参考组织模型生成R1和DVR参数图像,并计算早期和晚期SUVR。结果显示,帕金森病组与健康对照组在壳核的DVR和SUVRLP以及胃的SUVREP上存在显著差异,且两组黑质纹状体与消化区域的相关模式不同。

要点

  • 帕金森病组壳核DVR和SUVRLP显著低于健康对照组。
  • 帕金森病组胃SUVREP显著高于健康对照组。
  • 健康对照组中胃与黑质、胰腺与壳核存在相关性,帕金森病组中未发现这些相关性。

核心结论

  • 由SRTM模型生成的R1和DVR参数图像以及SUVREP和SUVRLP可用于量化健康对照和帕金森病组的动态全身[11C]CFT PET/CT。R1和DVR或SUVR识别的健康对照与帕金森病组之间黑质纹状体和消化区域相关模式的差异可能为疾病机制提供新见解。

研究设计与样本

  • 回顾性纳入11名参与者(6名健康对照和5名帕金森病患者),在全身PET/CT扫描仪(uEXPLORER, United Imaging Healthcare)上进行75分钟动态[11C]CFT扫描,获取四个黑质纹状体核团(尾状核、壳核、苍白球和黑质)和三个消化器官(胰腺、胃和十二指肠)的时间活度曲线,使用以枕叶为参考组织的SRTM和带有空间约束的线性回归算法生成R1和DVR全身参数图像,并计算早期(1-3分钟,SUVREP)和晚期(60-75分钟,SUVRLP)的SUVR作为R1和DVR的半定量替代指标。

主要发现

  • 健康对照组与帕金森病组在壳核的DVR和SUVRLP上存在显著差异:DVR为4.82 ± 1.58 vs. 2.58 ± 0.53(健康对照 vs. 帕金森病),SUVRLP为4.65 ± 1.36 vs. 2.84 ± 0.67(健康对照 vs. 帕金森病),两者p < 0.05。
  • 健康对照组与帕金森病组在胃的SUVREP上存在显著差异:1.12 ± 0.27 vs. 2.27 ± 0.65(健康对照 vs. 帕金森病),p < 0.01。
  • 在健康对照组中,胃与黑质在R1和SUVREP值上均呈负相关(R1:r=-0.83,p < 0.05;SUVREP:r=-0.94,p < 0.01)。
  • 在健康对照组中,胰腺与壳核在DVR和SUVRLP值上均呈正相关(DVR:r = 0.94,p < 0.01;SUVRLP:r = 1.00,p < 0.001)。
  • 在帕金森病组中,上述目标黑质纹状体和消化区域之间未发现相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Dynamic total-body imaging enables new perspectives to investigate the potential relationship between the central and peripheral regions. Employing uEXPLORER dynamic [11C]CFT PET/CT imaging with voxel-wise simplified reference tissue model (SRTM) kinetic modeling and semi-quantitative measures, we explored how the correlation pattern between nigrostriatal and digestive regions differed between the healthy participants as controls (HC) and patients with Parkinson's disease (PD). METHODS: Eleven participants (six HCs and five PDs) underwent 75-min dynamic [11C]CFT scans on a total-body PET/CT scanner (uEXPLORER, United Imaging Healthcare) were retrospectively enrolled. Time activity curves for four nigrostriatal nuclei (caudate, putamen, pallidum, and substantia nigra) and three digestive organs (pancreas, stomach, and duodenum) were obtained. Total-body parametric images of relative transporter rate constant (R1) and distribution volume ratio (DVR) were generated using the SRTM with occipital lobe as the reference tissue and a linear regression with spatial-constraint algorithm. Standardized uptake value ratio (SUVR) at early (1-3 min, SUVREP) and late (60-75 min, SUVRLP) phases were calculated as the semi-quantitative substitutes for R1 and DVR, respectively. RESULTS: Significant differences in estimates between the HC and PD groups were identified in DVR and SUVRLP of putamen (DVR: 4.82 ± 1.58 vs. 2.58 ± 0.53; SUVRLP: 4.65 ± 1.36 vs. 2.84 ± 0.67; for HC and PD, respectively, both p < 0.05) and SUVREP of stomach (1.12 ± 0.27 vs. 2.27 ± 0.65 for HC and PD, respectively; p < 0.01). In the HC group, negative correlations were observed between stomach and substantia nigra in both the R1 and SUVREP values (r=-0.83, p < 0.05 for R1; r=-0.94, p < 0.01 for SUVREP). Positive correlations were identified between pancreas and putamen in both DVR and SUVRLP values (r = 0.94, p < 0.01 for DVR; r = 1.00, p < 0.001 for SUVRLP). By contrast, in the PD group, no correlations were found between the aforementioned target nigrostriatal and digestive areas. CONCLUSIONS: The parametric images of R1 and DVR generated from the SRTM model, along with SUVREP and SUVRLP, were proposed to quantify dynamic total-body [11C]CFT PET/CT in HC and PD groups. The distinction in correlation patterns of nigrostriatal and digestive regions between HC and PD groups identified by R1 and DVR, or SUVRs, may provide new insights into the disease mechanism.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Xin M, Wang Y, Yang X, et al. Exploring the nigrostriatal and digestive interplays in Parkinson's disease using dynamic total-body [11C]CFT PET/CT. Eur J Nucl Med Mol Imaging. 2024. PMID: 38393375. doi:10.1007/s00259-024-06638-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。